
Rebastinib (DCC-2036)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
1020172-07-9
C16967-50mg
Bcr-Abl
Protein Tyrosine Kinase
CC (C) (C) C1=NN (C (=C1) NC (=O) NC2=C (C=C (C=C2) OC3=CC (=NC=C3) C (=O) NC) F) C4=CC5=C (C=C4) N=CC=C5
C30H28FN7O3
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1 (WT) and Abl1 (T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
2 years -80 in solvent
Beschrijving
Rebastinib (DCC-2036) Beschikbaar in 10 mM / 1 mL. Wordt geleverd met droogijs. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten

HyperLadder 1kb
BIO-33053
100 Lanes

MicroMolar UDP assay kit - 100 assays
MUD100K
100 Assays

MEM Amino Acids Solution (50x) w/o: L-Glutamine
P08-30100
100 mL

White glass slide, frosted
1380-20
1440/CS

Anti-TNF-α (Adalimumab), humanized Antibody
A1048-100
100 µg

PEPTIC DIGEST OF ANIMAL TISSUE (MEAT PEPTONE)
P16-102-01
500 g

GelRed® Agarose LE
#41029-5G
1x 5 g

HT115 (DE3) Super Competent Cells
D1045S
10x 100 μL
